The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. 1974

M D Freed, and J F Keane, and A Rosenthal

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011674 Pulse The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts. Pulses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004617 Embolism Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream. Embolus,Embolisms
D006328 Cardiac Catheterization Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures. Catheterization, Cardiac,Catheterization, Heart,Heart Catheterization,Cardiac Catheterizations,Catheterizations, Cardiac,Catheterizations, Heart,Heart Catheterizations
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin

Related Publications

M D Freed, and J F Keane, and A Rosenthal
January 1987, Pediatric cardiology,
M D Freed, and J F Keane, and A Rosenthal
January 1982, Pediatric cardiology,
M D Freed, and J F Keane, and A Rosenthal
January 2003, Pediatric cardiology,
M D Freed, and J F Keane, and A Rosenthal
August 1986, The American journal of cardiology,
M D Freed, and J F Keane, and A Rosenthal
August 1997, Catheterization and cardiovascular diagnosis,
M D Freed, and J F Keane, and A Rosenthal
January 1979, Revista espanola de cardiologia,
M D Freed, and J F Keane, and A Rosenthal
January 1979, Catheterization and cardiovascular diagnosis,
M D Freed, and J F Keane, and A Rosenthal
April 1969, Pediatrics,
M D Freed, and J F Keane, and A Rosenthal
February 1966, Lakartidningen,
Copied contents to your clipboard!